Home / Pharmaceutical company intelligence
Caliph Pharmaceuticals (Pvt) Ltd. logo
Pharmaceutical company intelligence

Caliph Pharmaceuticals (Pvt) Ltd.

Private pharmaceutical manufacturer · Risalpur · Pakistan

Risalpur-based pharmaceutical manufacturer producing tablets, capsules, liquids, powders and topical formulations.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date23 Jul 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Caliph Pharmaceuticals (Pvt.) Ltd.
Company type
Private pharmaceutical manufacturer
Address
Plot No. 17, Special Industrial Zone (EPZ), Risalpur, Khyber Pakhtunkhwa, Pakistan
Phone
+92 339 4091138
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
100%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000748 Caliph Pharmaceuticals (Pvt) Ltd. · Khyber Pakhtunkhwa
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000748 119 linked products · source seen 23 Sep 2026 View source ↗
Corporate profile source ledger Logo Url source ↗ Contact Page Url source ↗ Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx119public portfolio records represented
REG84unique registrations represented
IDX65indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR116current validated price records
G45generic molecules in indexed catalogue
DF12dosage-form groups
TA8therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage97%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage89%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixCaliph Pharmaceuticals (Pvt) Ltd.Share of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/caliph-pharmaceuticals-pvt-ltdGenerated 23 Sep 2026Anti-infectives65 · 55%Dermatology12 · 10%Vitamins, minerals & nutrition11 · 9%Gastrointestinal & hepatology11 · 9%Pain & musculoskeletal8 · 7%CNS & mental health6 · 5%Oncology & immunology3 · 3%Other therapeutic areas3 · 3%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioCaliph Pharmaceuticals (Pvt) Ltd.Distribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/caliph-pharmaceuticals-pvt-ltdGenerated 23 Sep 2026119presentationsTablet31 · 26%Suspension26 · 22%Capsule11 · 9%Injection10 · 8%Cream9 · 8%Lotion9 · 8%Other forms23 · 19%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionCaliph Pharmaceuticals (Pvt) Ltd.Current company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/caliph-pharmaceuticals-pvt-ltdGenerated 23 Sep 2026106comparable productsBelow peer median62 · 58%Near peer median29 · 27%Above peer median15 · 14%Company median price position-7.7%Lowest-price equivalents16Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsCaliph Pharmaceuticals (Pvt) Ltd.Companies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/caliph-pharmaceuticals-pvt-ltdGenerated 23 Sep 2026Neutro Pharma (Pvt.) Ltd.,28 shared62% overlapPharmasol (Pvt) Ltd.27 shared60% overlapValor Pharmaceuticals26 shared58% overlapMediate Pharmaceutical Pvt Ltd25 shared56% overlapS.J & G. Fazul Ellahie (pvt) limite…25 shared56% overlapM/s. Genix Pharma (Pvt) Ltd.24 shared53% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives65 products · 55%
Dermatology12 products · 10%
Vitamins, minerals & nutrition11 products · 9%
Gastrointestinal & hepatology11 products · 9%
Pain & musculoskeletal8 products · 7%
CNS & mental health6 products · 5%
Oncology & immunology3 products · 3%
Respiratory & allergy3 products · 3%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Macrolide antibacterials12 products · 10%
Topical corticosteroids / anti-inflammatory dermatologics12 products · 10%
Vitamins / minerals / hematinics11 products · 9%
Fluoroquinolone antibacterials9 products · 8%
Analgesics / NSAIDs8 products · 7%
Third-generation cephalosporins7 products · 6%
Antimalarials6 products · 5%
Proton pump inhibitors6 products · 5%
Formulation footprint

Dosage forms

Tablet31 products
Suspension26 products
Capsule11 products
Injection10 products
Cream9 products
Lotion9 products
Syrup8 products
Ointment5 products
Sachet4 products
Solution3 products
Infusion2 products
Drops1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 CalphacinClarithromycin 6presentations 125 mg/5 mL, 250 mg, 250 mg/5 mL, 500 mg · Suspension, Tablet #2 CalsicOmeprazole 6presentations 20 mg, 40 mg · Capsule, Injection #3 RiscalmRisperidone 5presentations 1 mg, 2 mg, 3 mg, 4 mg · Tablet, Solution #4 Betacline-GBetamethasone + Gentamicin 4presentations 0.5 mg + 1 mg, 0.5 mg/g + 1 mg/g · Ointment, Cream #5 Betacline-SBetamethasone + Salicylic acid 4presentations 0.05% + 2%, 0.5 mg + 20 mg, 0.5 mg + 30 mg, 0.5 mg/g + 30 mg/g · Lotion, Ointment #6 CalaziAzithromycin 4presentations 1 g, 250 mg, 500 mg · Sachet, Capsule, Tablet
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median6258% of comparable products
Near market median29within ±5% of median
Above market median1514% of comparable products
Lowest-price equivalents16ties included
Company median price position -7.7% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Betacline 0.05%Betamethasone · Ointment · 15gm PKR 3.52/g-50.9% vs market median Calworm 200 mgAlbendazole · Tablet · 1x2's PKR 8.80/tablet-44.0% vs market median Calsic 20 mgOmeprazole · Capsule · 10x10's PKR 13.88/capsule-29.5% vs market median Calsic 40 mgOmeprazole · Capsule · 10x10's PKR 25.44/capsule-26.6% vs market median Hydrocortisone 1 %Hydrocortisone · Cream · 20gm PKR 4.43/g-23.7% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Neutro Pharma (Pvt.) Ltd.,210 products · 97 generics 28shared generics Pharmasol (Pvt) Ltd.257 products · 102 generics 27shared generics Valor Pharmaceuticals219 products · 97 generics 26shared generics Mediate Pharmaceutical Pvt Ltd236 products · 90 generics 25shared generics S.J & G. Fazul Ellahie (pvt) limited.193 products · 68 generics 25shared generics M/s. Genix Pharma (Pvt) Ltd.297 products · 97 generics 24shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers84Distinct registrations among indexed, published, presentation-validated products only
Verified price observations119
Products with a verified price119
Products with multiple price observations0
Source records with multiple versions116
Latest portfolio source check22 Sep 2026
Latest effective price date23 Jul 2026
Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

84 unique registration(s) · 65 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Intelligence filter: Therapeutic areaAnti-infectives Clear intelligence filters
Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
A-zatro Azithromycin 200 mg/5 mL Dry suspension 15ml 080405 PKR 290.35 PKR 19.36/mL 9% below median
Betacline Betamethasone + Gentamicin 0.5 mg + 1 mg Cream 15gm 096918 PKR 112.61 PKR 7.51/g 8% above median
Betacline-G Betamethasone + Gentamicin 0.5 mg + 1 mg Cream 15gm 096918 PKR 112.61 PKR 7.51/g 8% above median
Betacline-G Betamethasone + Gentamicin 0.5 mg/g + 1 mg/g Cream 30gms 096918 PKR 220.09 PKR 7.34/g No comparator
Betacline-G Betamethasone + Gentamicin 0.5 mg + 1 mg Ointment 15gm 096919 PKR 114.31 PKR 7.62/g No comparator
Betacline-G Betamethasone + Gentamicin 0.5 mg/g + 1 mg/g Ointment 30gms 096919 PKR 223.50 PKR 7.45/g No comparator
Caladar Sulfadoxine + Pyrimethamine 500 mg + 25 mg Suspension 15ml 080247 PKR 25.59 PKR 1.71/mL 30% below median
Caladar Sulfadoxine + Pyrimethamine 500 mg + 25 mg Suspension 30ml 080247 PKR 73.36 PKR 2.45/mL 43% above median
Calazi Azithromycin 250 mg Capsule 6's 073399 PKR 269.22 PKR 44.87/capsule 9% below median
Calazi Azithromycin 250 mg Capsule 10's 073399 PKR 448.71 PKR 44.87/capsule 9% below median
Calazi Azithromycin 500 mg Tablet 6's 104160 PKR 483.91 PKR 80.65/tablet 5% below median
Calazi Azithromycin 1 g Sachet 1's 104161 PKR 158.37 PKR 158.37/sachet 12% below median
Calmether Dry Artemether + Lumefantrine 15 mg + 90 mg/5 mL Dry suspension 60ml 075554 PKR 307.10 PKR 5.12/mL 13% below median
Calmether Dry Artemether + Lumefantrine 15 mg + 90 mg/5 mL Dry suspension 30ml 075554 PKR 153.55 PKR 5.12/mL 13% below median
Calpem Meropenem 500 mg Injection 1's 104132 PKR 1,882.84 PKR 1,882.84/vial/unit 9% below median
Calpem Meropenem 1 g IV injection 1's 104133 PKR 3,519.32 PKR 3,519.32/vial/unit 9% below median
Calphacin Clarithromycin 125 mg/5 mL Suspension 60ml 075555 PKR 392.41 PKR 6.54/mL 11% below median
Calphacin Clarithromycin 125 mg/5 mL Suspension 30ml 075555 PKR 197.08 PKR 6.57/mL 11% below median
Calphacin Clarithromycin 250 mg Tablet 1x10's 087430 PKR 422.31 PKR 42.23/tablet 11% below median
Calphacin Clarithromycin 500 mg Tablet 1x10's 087431 PKR 703.86 PKR 70.39/tablet 16% below median
Calphacin Clarithromycin 250 mg/5 mL Dry suspension 70ml 091284 PKR 665.68 PKR 9.51/mL 18% below median
Calphacin Clarithromycin 250 mg/5 mL Dry suspension 60ml 091284 PKR 647.56 PKR 10.79/mL 7% below median
Calphacin ER Clarithromycin 500 mg Tablet 1x5's 087429 PKR 364.25 PKR 72.85/tablet 13% below median
Calworm Albendazole 200 mg Tablet 1x2's 074504 PKR 17.59 PKR 8.80/tablet 44% below median
Cipak Ciprofloxacin 250 mg Tablet 1x10's 079351 PKR 228.75 PKR 22.88/tablet 10% below median
Cipak Ciprofloxacin 500 mg Tablet 1x10's 079352 PKR 378.32 PKR 37.83/tablet 12% below median
Cipak Ciprofloxacin 750 mg Tablet 1x10's 091286 PKR 404.72 PKR 40.47/tablet Near median
Cipcal Ciprofloxacin 125 mg/5 mL Dry suspension 60ml 075552 PKR 211.89 PKR 3.53/mL Near median
Cipcal Fort Ciprofloxacin 250 mg/5 mL Dry suspension 60ml 075553 PKR 281.55 PKR 4.69/mL 8% below median
Clindacal Clindamycin 1% Lotion 30ml 096916 PKR 255.91 PKR 8.53/mL No comparator
Clindacal Viginal Clindamycin 2% Cream 40gm 096917 PKR 489.64 PKR 12.24/g 10% below median
Coropulp Hydroxychloroquine 200 mg Tablet 5x10's 101273 PKR 791.84 PKR 15.84/tablet 10% above median
Coropulp Hydroxychloroquine 200 mg Tablet 3x10's 101273 PKR 475.11 PKR 15.84/tablet 10% above median
Enzid Linezolid 100 mg/5 mL Dry suspension 60ml 085896 PKR 615.88 PKR 10.26/mL Near median
Enzid Linezolid 100 mg Dry suspension 120ml 085896 PKR 1,170.18 PKR 9.75/mL No comparator
Enzid Linezolid 600 mg Tablet 2x6's 087432 PKR 4,497.69 PKR 374.81/tablet Near median
Enzid Linezolid 600 mg/300 mL IV infusion 300ml 095223 PKR 1,055.79 PKR 3.52/mL 13% below median
Flucal Dry Fluconazole 50 mg/5 mL Dry suspension 35ml 080591 PKR 369.53 PKR 10.56/mL 10% below median
Grancef Cefixime 100 mg/5 mL Dry suspension 30ml 082560 PKR 299.45 PKR 9.98/mL Near median
Grancef Cefixime 200 mg/5 mL Dry suspension 30ml 082561 PKR 366.45 PKR 12.22/mL Near median
Grancef Cefixime 400 mg Capsule 1x5's 085919 PKR 536.59 PKR 107.32/capsule Near median
Keklofz Fluconazole 150 mg Capsule 1's 093910 PKR 242.84 PKR 242.84/capsule 8% below median
Levocal Levofloxacin 250 mg Tablet 1x10's 079353 PKR 439.92 PKR 43.99/tablet 9% below median
Levocal Levofloxacin 500 mg Tablet 1x10's 079354 PKR 732.02 PKR 73.20/tablet 7% below median
Metronidazole Metronidazole (Benzoate) 200 mg/5 mL Suspension 90ml 079356 PKR 84.46 PKR 0.94/mL Near median
Metronidazole Metronidazole (Benzoate) 200 mg/5 mL Suspension 60ml 079356 PKR 56.31 PKR 0.94/mL Near median
Metronidazole Metronidazole 200 mg Tablet 20x10's 100957 PKR 351.93 PKR 1.76/tablet 18% below median
Metronidazole Metronidazole 400 mg Tablet 10x10's 100958 PKR 263.95 PKR 2.64/tablet 12% below median
Nixcal Permethrin 5 % Lotion 90ml 096914 PKR 235.89 PKR 2.62/mL Near median
Nixcal Permethrin 5 % Lotion 60ml 096914 PKR 157.26 PKR 2.62/mL Near median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Caliph Pharmaceuticals (Pvt) Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/company/caliph-pharmaceuticals-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.